| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041158A2 Peptide epoxyketones for proteasome inhibition |
| 04/01/2009 | EP2041135A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 04/01/2009 | EP2041127A2 Indole compounds |
| 04/01/2009 | EP2041117A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 04/01/2009 | EP2041100A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2040750A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 04/01/2009 | EP1974016A4 Mesenchymal stem cells and uses therefor |
| 04/01/2009 | EP1845780A4 Uses of methylphenidate derivatives |
| 04/01/2009 | EP1572241B1 Oral pharmaceutical compositions comprising cyclosporin |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/01/2009 | EP1450804B9 Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1126828B1 Oral administration of adenosine analogs |
| 04/01/2009 | EP1119623B1 Mage-a3 peptides presented by hla class ii molecules |
| 04/01/2009 | CN101400785A Method for production of T cell population |
| 04/01/2009 | CN101400703A Domain antibody construct |
| 04/01/2009 | CN101400659A Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 04/01/2009 | CN101400346A Pharmaceutical combination composition comprising at least one PKC inhibitor and at least one JAK3 kinase inhibitor for treating autoimmune disorders |
| 04/01/2009 | CN101400344A Composition for improving cellular membrane composition and function |
| 04/01/2009 | CN101397346A Method for preparing asparagus pure polysaccharide having immunoregulation role |
| 04/01/2009 | CN101397330A Novel nitrogen-containing medicament with anti-inflammatory activity |
| 04/01/2009 | CN101397328A Nitric oxide-releasing glucocorticosteroid |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 04/01/2009 | CN101396531A Traditional Chinese medicine for treating allergic purpura |
| 04/01/2009 | CN101396511A Mixed traditional Chinese medicine health-care wine |
| 04/01/2009 | CN101396378A Nano gene peptides products and preparation method and use thereof |
| 04/01/2009 | CN101396372A Use of C60 polyhydroxy derivates in preventing and treating related disease of mitochondria damage |
| 04/01/2009 | CN101396371A Quality control method of Tibet crude-medicine processing material and new use thereof |
| 04/01/2009 | CN101396368A Use of iso-glycyrrhizic acid and salt thereof in treating allergic rhinitis |
| 04/01/2009 | CN101396365A Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 04/01/2009 | CN100473417C Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 04/01/2009 | CN100473414C Nutrient liquid for body building and immunity enhancement and preparing method thereof |
| 04/01/2009 | CN100473384C Pharmaceutical formulations comprising an immune response modifier |
| 04/01/2009 | CN100473377C Process for producing soft gelatin capsule |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511078 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511010 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | US7510698 Adjuvant formulation consisting essentially of a metabolizable oil and alpha tocopherol in emulsion for enhancing immune response to infection |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/31/2009 | CA2349268C A process for the preparation of suspensions of drug particles for inhalation delivery |
| 03/26/2009 | WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 03/26/2009 | WO2009038671A2 Oxylipin compounds for treating autoimmune diseases |
| 03/26/2009 | WO2009037719A1 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors |
| 03/26/2009 | WO2009037439A2 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 03/26/2009 | WO2009036772A1 Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
| 03/26/2009 | WO2009036568A1 Methods and compositions for treating tumors and viral infections |
| 03/26/2009 | WO2008135791A8 Imidazoquinolines with immuno-modulating properties |
| 03/26/2009 | WO2008097824A3 Use of arsenic compounds for treatment of pain and inflammation |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082400 Soluble pyrone analogs methods and compositions |
| 03/26/2009 | US20090082398 Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| 03/26/2009 | US20090082385 Deuterium-enriched desloratidine |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082349 Thiazolones for use as pi3 kinase inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082332 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082311 2-Aminobutanol Compound and Use Thereof for Medical Purposes |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082260 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081284 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
| 03/26/2009 | US20090081257 Hydrogenase deficient bacterial strains |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081250 Compositions and methods for treatment of cervical cancer |
| 03/26/2009 | US20090081248 Non-hemolytic LLO fusion proteins and methods of utilizing same |
| 03/26/2009 | US20090081247 Immune adjuvant comprising ATP |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein |
| 03/26/2009 | US20090081236 Immunizing compositions and methods of use |
| 03/26/2009 | US20090081231 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 03/26/2009 | US20090081229 Anti-pro87299 antibodies |
| 03/26/2009 | US20090081219 Human monoclonal antibodies against CD25 |
| 03/26/2009 | US20090081211 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081202 Immunogenic compositions and methods |
| 03/26/2009 | US20090081198 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 03/26/2009 | US20090081194 Compositions and methods for reducing risk of development, or severity, of inappropriate immune response in eyes |
| 03/26/2009 | US20090081185 Apoptotic agents |